Trade-Ideas LLC identified PRA Health ( PRAH) as a pre-market mover with heavy volume candidate. In addition to specific proprietary factors, Trade-Ideas identified PRA Health as such a stock due to the following factors:

  • PRAH has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $19.1 million.
  • PRAH traded 46,281 shares today in the pre-market hours as of 8:22 AM, representing 11.1% of its average daily volume.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in PRAH with the Ticky from Trade-Ideas. See the FREE profile for PRAH NOW at Trade-Ideas

More details on PRAH: PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development services to the biotechnology and pharmaceutical industries worldwide. PRAH has a PE ratio of 38. Currently there are 5 analysts that rate PRA Health a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for PRA Health has been 400,300 shares per day over the past 30 days. PRA Health has a market cap of $3.0 billion and is part of the health care sector and health services industry. Shares are up 7.4% year-to-date as of the close of trading on Thursday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates PRA Health as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, weak operating cash flow and poor profit margins. Highlights from the ratings report include:

  • PRAH's revenue growth has slightly outpaced the industry average of 7.0%. Since the same quarter one year prior, revenues rose by 10.7%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • PRA HEALTH SCIENCES INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, PRA HEALTH SCIENCES INC turned its bottom line around by earning $1.29 versus -$0.37 in the prior year. This year, the market expects an improvement in earnings ($2.38 versus $1.29).
  • Net operating cash flow has decreased to $2.70 million or 20.61% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Life Sciences Tools & Services industry. The net income has significantly decreased by 192.9% when compared to the same quarter one year ago, falling from $17.19 million to -$15.97 million.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.